LianBio
LIANY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $28,693 | $482,402 | $176,994 | $660,814 |
| - Cash | $51,702 | $438,584 | $79,221 | $228,177 |
| + Debt | $0 | $2,457 | $4,339 | $4,834 |
| Enterprise Value | -$23,009 | $46,275 | $102,112 | $437,471 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$801 | -$1,327 | -$1,005 | -$526 |
| % Margin | – | – | – | – |
| EBITDA | $3,256 | $312,914 | -$109,487 | -$195,516 |
| % Margin | – | – | – | – |
| Net Income | $2,476 | $311,137 | -$110,159 | -$196,561 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.023 | 2.87 | -1.02 | -1.83 |
| % Growth | -99.2% | 381.4% | 44.3% | – |
| Operating Cash Flow | $3,747 | $258,936 | -$99,067 | -$164,171 |
| Capital Expenditures | $0 | -$375 | -$1,843 | -$948 |
| Free Cash Flow | $3,747 | $258,561 | -$100,910 | -$165,119 |